Sector Chart MPX Bioceutical Corp

Equities

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		+5.36%	+34.09%

2020	IAnthus and MPX Bioceutical Receives Demand for Payment and Notice of Intention to Enforce Security	CI
2019	IAnthus Capital Holdings, Inc. completed the acquisition of MPX Bioceutical Corporation.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E ratio